While there will always be vast differences at the individual level in how various recreational drugs affect people, there are also some group level trends that align with biological sex differences. Sadly, the research on these differences has historically been sparse, making it difficult to give much sex-specific harm reduction advice on firm ground, but this article outlines three areas that women might want to pay particular attention to.
(Most of the available research on women and drug use is based on a binary understanding of gender and primarily involves cisgender participants. Where specific knowledge exists about transfeminine people or trans women on hormone therapy, we have highlighted this in the text.)